Chief People Officer · Health Catalyst, Inc. (HCAT)

Linda Llewelyn

A named executive officer of Health Catalyst in every fiscal year CompBrief holds from FY2020 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,409,780

Salary $373,333Stock awards $924,666

FY2023: $1,057,490

4th of 6 named executive officers at Health Catalyst by FY2024 total.

6 named officers on file for Health Catalyst, FY2024

Linda Llewelyn’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • HCAT’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Health Catalyst’s whole pay program stands against its peers

  • Health Catalyst’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HCAT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 19, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Linda Llewelyn’s full pay file as a PDF — free

More than this page: up to 10 years of Linda’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Linda Llewelyn compensation by year

Health Catalyst Summary Compensation Table · all 3 fiscal years held
In US dollars, as Health Catalyst reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2023FY2024
Salary$250,000$307,500$373,333
Bonus$0$0$0
Stock awards$852,750$693,019$924,666
Option awards$0$0$0
Non-equity incentive$28,750$40,840$95,071
Pension and deferred compensation$0$0$0
All other$9,096$16,131$16,709
Total$1,140,596$1,057,490$1,409,780

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Health Catalyst, Inc. DEF 14A filed May 19, 2025, accession 0001636422-25-000075, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Health Catalyst, Inc. filed document, accession 0001636422-25-000075. Every figure is read from that document and cited to the page and table it appears in. Filed May 19, 2025.

$1.1M
$1.1M
$1.4M
FY20
FY23
FY24
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU43,333$306,364—
PSU32,500$229,775—
RSU17,500$123,725—
PSU11,667$82,486—
RSU8,750$61,863—

Per the Outstanding Equity Awards at Fiscal Year-End table in Health Catalyst, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

8 Form 4 lines since the FY2024 proxy (filed May 19, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-01Tax withholding—8,519$1.37321,132
2026-03-02Tax withholding—13,836$1.66329,651
2026-02-26Tax withholding—4,471$1.75343,487
2026-02-25Grant or award—191,500$0.00334,763
2026-02-25Grant or award—13,195$0.00347,958
2025-12-01Tax withholding—9,762$2.90143,263
2025-09-02Tax withholding—2,854$3.36153,025
2025-06-02Tax withholding—2,965$3.63155,879

The 8 most recent of 8 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments Health Catalyst discloses, by trigger · FY2024
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$288,750$0$11,241$299,991
Change in control and involuntary termination$577,500$804,213$14,988$1,396,701

Per the Potential Payments Upon Termination or Change in Control table in Health Catalyst, Inc.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.

Health Catalyst’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Daniel BurtonChief Executive Officer$5,494,141
Kevin FreemanChief Commercial Officer$2,163,478
Benjamin LandryGeneral Counsel$1,572,148
Linda Llewelyn · this pageChief People Officer$1,409,780
Jason AlgerChief Financial Officer$1,287,155
Bryan HuntFormer Chief Financial Officer$798,455

The full Health Catalyst compensation record

free company brief

This page is one person within Health Catalyst's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Health Catalyst proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Health Catalyst's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Linda Llewelyn's compensation dossier · One-time report. No refunds.